8-K: PACS Group Reports Strong FY25 Results, Guides Higher for 2026

PACS Group, a leading post-acute healthcare company, announced robust financial results for fiscal year and fourth quarter 2025, alongside optimistic 2026 guidance.

Summary

• Full Year 2025 Revenue was $5.29 billion, marking a significant increase of 29.3% over the prior year.
• Full Year 2025 Net income reached $191.5 million.
• Full Year 2025 Adjusted EBITDA stood at $505.0 million, and Adjusted EBITDAR was $883.9 million.
• Fourth Quarter 2025 Revenue was $1.36 billion, an increase of 12.4% compared to the same period in the prior year.
• Fourth Quarter 2025 Net income was $59.8 million, with Adjusted EBITDA at $142.1 million and Adjusted EBITDAR at $237.7 million.
• 207 facilities, representing 73.4% of the skilled nursing portfolio, achieved a 4 or 5 star CMS Quality Measure rating, with mature facilities averaging 4.4 stars.
• Mature facilities maintained a high occupancy rate of 94.9%, significantly above the industry average of 78.7%.
• Cash provided by operating activities for the twelve months ended December 31, 2025, was $404.2 million.
• Cash and cash equivalents as of December 31, 2025, increased to $197.0 million from $157.7 million as of December 31, 2024.
• During 2025, 8 operating facilities were added, including 655 skilled nursing beds and 271 assisted living and independent living beds.
• The current portfolio comprises 323 healthcare operations across 17 states, with 56 facilities owned and options on 58 additional facilities.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive report, driven by significant revenue and earnings growth, robust operational metrics, and an optimistic outlook, despite some declines in ramping and new facility metrics.

Positives

• Significant revenue growth: 29.3% for FY2025 to $5.29 billion and 12.4% for Q4 2025 to $1.36 billion.
• Strong net income and Adjusted EBITDA performance for both the full year and fourth quarter of 2025.
• High quality ratings: 73.4% of skilled nursing facilities achieved 4 or 5 star CMS ratings, with mature facilities averaging 4.4 stars.
• Superior occupancy rates: Mature facilities at 94.9% compared to an industry average of 78.7%.
• Robust cash generation: $404.2 million from operating activities in 2025.
• Increased cash position: $197.0 million cash and cash equivalents as of December 31, 2025, up from $157.7 million in 2024.
• Strategic expansion: Added 8 operating facilities in 2025 and 3 more since Q4 end, increasing total operated facilities to 323.
• Positive 2026 guidance for revenue ($5.65 billion $5.75 billion) and Adjusted EBITDA ($555 million $575 million).

Negatives

• Ramping facilities experienced declines in skilled services revenue (-27.1%), skilled mix by nursing revenue (-12.4%), skilled mix by nursing days (-8.8%), and occupancy rate (-7.6%) in 2025 compared to 2024.
• New facilities also saw a slight decrease in occupancy rate (-2.1%) and skilled mix by nursing revenue (-1.5%).
• Skilled mix by nursing revenue for total facilities decreased by 1.5% to 48.8% in 2025.
• Skilled mix by nursing days for total facilities decreased by 0.5% to 28.7% in 2025.

Risks

• Dependence on third-party payors, including adverse changes in patient acuity, payor mix, payment methodologies, and cost-containment initiatives.
• Potential inability to obtain full reimbursement for services billed under consolidated billing or bundled payments.
• Exposure to increased labor costs and staffing shortages of nurses, nurse assistants, and other skilled personnel, and potential monetary fines.
• State regulatory actions or deregulation affecting healthcare services, facility construction, expansion, or acquisition.
• Ability to attract and retain patients and residents and to compete effectively with other healthcare providers.
• Internal audits and reviews that may result in billing adjustments, repayments, fines, or other corrective actions.
• Ongoing and future litigation and self-insurance exposure.
• Material weaknesses in internal control over financial reporting and risks related to remediation or the emergence of additional material weaknesses.
• Failures to provide consistently high-quality care or employee conduct that adversely affects patient health, safety, welfare, or clinical treatment.
• Reliance on information technology and the risk that failures, inadequacies, or interruptions could disrupt operations.
• Reliance on internally calculated operational metrics that may be subject to measurement challenges or perceived inaccuracies.
• Ability to complete, integrate, and realize expected benefits from acquisitions at attractive prices or dispose of underperforming or non-strategic operating subsidiaries.
• Potential costs, liabilities, and regulatory issues arising from acquisitions.
• Ability to complete partnerships that increase capacity consistent with growth strategy.
• Ability to achieve or maintain competitive quality of care ratings from CMS or private organizations.
• Ability to obtain insurance at acceptable costs.
• Geographic concentration of facilities that exposes the company to local economic downturns, regulatory changes, or natural disasters.
• Impact of actions by national labor unions.
• Risks associated with leased real property, including lease terminations, extensions, and special charges.
• Failure to generate sufficient cash flow to meet long-term debt, mortgage, and lease obligations and covenants, which could lead to defaults or loss of facilities.
• Ability to obtain additional capital on acceptable terms, or at all.
• Extensive and evolving legal and regulatory compliance obligations and the potential costs to achieve or maintain compliance.
• Substantial control of the company by founders, which may result in conflicts of interest or the appearance of conflicts.
• Status as a "controlled company" under NYSE rules and the governance implications of relying on applicable exemptions.

Future Outlook

PACS Group provides full-year 2026 guidance, expecting revenue in the range of $5.65 billion to $5.75 billion and Adjusted EBITDA in the range of $555 million to $575 million. The company plans to continue expanding its footprint through a balanced approach to leasing and acquiring real estate, actively evaluating opportunities for both high-performing and underperforming operations across multiple states, with the goal of driving growth and unlocking long-term value.

Management Comments

• "We're pleased with our overall 2025 results, which reflect our commitment to exceptional patient care, superb quality, consistent operational excellence, and forward-looking strategic growth. These results support our differentiated business model and our optimism for ongoing success." Jason Murray, CEO.
• "Quality care remains a key metric: PACS currently has a total of 207 facilities rated 4 or 5 QM Stars, including 80 Four-Star facilities and 127 Five-Star facilities — a key driver of our 29.3% revenue growth in 2025 compared to the prior year." Jason Murray, CEO.
• "This year's strong revenue growth also reflects the full year contribution from facilities acquired in 2024, as well as the addition of 655 skilled nursing beds across 4 skilled facilities, and 271 assisted living and independent living units across 4 senior living facilities, over the 12 months ending December 31, 2025." Mark Hancock, Interim CFO.
• "We also continue to execute on our strategic and disciplined growth strategy. Since the end of the fourth quarter, we've added 3 facilities and divested one, bringing our current total operated facilities to 323 and our properties wholly owned or owned through JV partnerships to 105. With our locally-led, centrally-supported operating model and experience integrating larger acquisitions, we expect the transitions will be seamless." Mark Hancock, Interim CFO.
• "Our performance validates our core strengths and our capacity and ability to adapt to market conditions, regulatory changes, and the ongoing evolution of the post-acute care industry. We thank our stakeholders for their support and trust in PACS and remain committed to providing the quality care that our patients have come to expect from us." Jason Murray, CEO.

Industry Context

StockSavvy.ai notes that PACS Group's strong performance, particularly its high CMS Quality Measure Star ratings and superior mature facility occupancy rates (94.9% vs. 78.7% industry average), positions it favorably within the competitive post-acute healthcare sector. The company's strategic focus on acquiring both high-performing and underperforming operations aligns with broader industry trends of consolidation and value creation in a fragmented market, especially given the increasing demand for quality post-acute care services.

Comparison to Industry Standards

• Mature facilities occupancy rate of 94.9% significantly exceeds the industry average of 78.7%, demonstrating superior operational efficiency and patient demand.
• 73.4% of the skilled nursing portfolio achieved a 4 or 5 star CMS Quality Measure Star rating, with mature facilities averaging 4.4 stars, indicating strong quality performance relative to general industry benchmarks.
• The company's growth strategy, including the addition of 8 operating facilities in 2025 and 3 more since year-end, demonstrates an aggressive expansion pace compared to many competitors in the post-acute care space.

Management Changes

Legal Proceedings

• Ongoing and future litigation.
• Self-insurance exposure.
• Legal and professional fees incurred associated with the Audit Committee's independent investigation and with other ongoing investigations (mentioned as an adjustment to EBITDA).

Stakeholder Impact

• Shareholders: Positive financial results and outlook are highly likely to benefit shareholders through potential stock appreciation and improved company valuation.
• Patients/Residents: The company's commitment to exceptional patient care and high quality ratings (73.4% of facilities with 4 or 5 QM Stars) indicates a positive impact on patient health and welfare.
• Employees: Increased labor costs and staffing shortages are mentioned as a risk, suggesting potential challenges or a focus on employee retention and compensation.
• Creditors: Strong cash flow from operations ($404.2 million) and improved financial performance enhance the company's ability to meet its long-term debt, mortgage, and lease obligations.
• Suppliers: Continued growth and expansion of facilities may lead to increased demand for supplies and services from vendors.

Next Steps

• Host a live webcast and conference call on February 26, 2026, at 5:30 p.m. Eastern time to discuss financial results.
• Continue to execute on strategic and disciplined growth strategy, including evaluating opportunities to acquire both high-performing and underperforming operations.
• Expand footprint through a balanced approach to leasing and acquiring real estate.

Key Dates

Recommendation

The company delivered exceptional full-year 2025 financial results, marked by substantial revenue growth (29.3%) and a significant increase in net income and Adjusted EBITDA. Operational KPIs, such as mature facility occupancy rates (94.9% vs. 78.7% industry average) and high CMS quality ratings, demonstrate strong underlying business health and competitive advantage. The positive 2026 guidance further reinforces confidence in future performance and strategic growth initiatives. While there are some declines in ramping and new facility metrics, the overall trajectory and management's proactive growth strategy suggest strong potential for continued value creation.

Keywords

post-acute healthcare, skilled nursing, assisted living, senior living, CMS Quality Measure, occupancy rates, EBITDA, EBITDAR, healthcare facilities, financial results, earnings, PACS Group, NYSE: PACS